Company / Cost of Revenue
Processa Pharmaceuticals, Inc. Cost of Revenue History
FY2013-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$125.9K
FY2016
5-year range
$66.8K / $188.0K
FY2013-FY2016
Trend
+88.3%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $188,002 to $125,876 over the past 2 years.
Based on SEC 10-K filings.
$125,876 in FY2016 with a 3-year CAGR of -1.9%.
Improved from $188,002 to $125,876 over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -1.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -1.9%, indicating a declining trend.
- In FY2016, cost of revenue increased 88.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | - | - |
| FY2016 | $125.9K | +88.3% |
| FY2015 | $66.8K | -64.5% |
| FY2014 | $188.0K | +41.1% |
| FY2013 | $133.3K | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026